Certainly, human patients with T2DM display a blunted incretin effect of GLP-1, and defects in meal-induced intestinal GLP-1 secretion (91), suggesting that the paracrine action of alpha-cell-derived GLP-1 may be necessary to combat this diminished peripheral incretin action of gut-derived GLP-1
Median overall survival was 31.5 months for the combo versus 16.1 months for chemotherapy
Your provider will assess your goals, create a personalized plan, and determine the right prescription for you
Otherwise, they risk losing lean muscle, which is essential for metabolism, strength, and long-term health
Tirzepatide mimics both of them
SURMOUNT-5, the first head-to-head trial (published in NEJM, 2025), found tirzepatide produced about 20.2% average weight loss versus 13.7% for semaglutide over 72 weeks